Table 2.
Qualitative VP1u Results | Qualitative VLP IgG Results | |||
---|---|---|---|---|
Qualitative Neutralization Results | Positive | Negative | Positive | Negative |
Positive a | 40 | 1 | 36 | 5 |
Negative | 0 | 8 | 1 | 7 |
Kappa coefficient (95% CI) | 0.93 (0.79, 1.00) | 0.63 (0.36, 0.89) | ||
Sensitivity (95% CI) | 97.6% (87.1%, 99.9%) | 87.8% (73.8%, 95.9%) | ||
Specificity (95% CI) | 100% | 87.5% (47.4%, 99.7%) |
a Serum samples were obtained from patients 120 days after hospitalization for acute parvovirus B19 infection or from additional patients who were not experiencing aplastic crisis.